Delivery Order SPE2DB22D2214-SPE2DB25FS4CY

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,758.18, is for the delivery of 4567503375 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a $3,041.88 delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) on May 6, 2024. The contract is for the provision of 4564513309 ! VEVYE 0.1% EYE DROP 2ML, with a firm fixed price and an ultimate completion date of May 7, 2024. The award was made on a full and open competition basis without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a $999,999,999.00...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.02, is for the supply of a 0.1% eye drop medication (VEVYE 2ML). The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.18, is a Firm Fixed Price Delivery Order with a completion date of December 23, 2024. The contract covers the delivery of the medical product "4566778896 ! VEVYE 0.1% EYE DROP 2ML" and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,448.71 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,214.18, is for the procurement of VEVYE 0.1% eye drops in 2ml units. The contract has a firm fixed price pricing type and an ultimate completion date of May 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract ID is SPE2DB20D3505|SPE2DB25FT2F6 and it is a $2,449.64 firm fixed price delivery order for the supply of "VEVYE 0.1% EYE DROP 2ML" pharmaceutical products. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite...
This federal contract award is a firm fixed price delivery order worth $14,390.05, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of a pharmaceutical product, "VEVYE 0.1% EYE DROP 2ML," with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with DLA valued...
This federal contract award, valued at $8,173.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4564310851 ! VEVYE 0.1% EYE DROP 2ML, with a firm fixed price and an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS4CY
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,031.27, is for the supply of 4567556748 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement.

Generated 6/9/25, 9:44 AM